These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 31599967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lacticaseibacillus rhamnosus FM9 and Limosilactobacillus fermentum Y57 Are as Effective as Statins at Improving Blood Lipid Profile in High Cholesterol, High-Fat Diet Model in Male Wistar Rats.
    Zafar H, Ain NU, Alshammari A, Alghamdi S, Raja H, Ali A, Siddique A, Tahir SD, Akbar S, Arif M, Alharbi M, Rahman A.
    Nutrients; 2022 Apr 15; 14(8):. PubMed ID: 35458216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hypocholesterolemic Effect of Potential Probiotic Lactobacillus fermentum Strains Isolated from Traditional Fermented Foods in Wistar Rats.
    Thakkar PN, Patel A, Modi HA, Prajapati JB.
    Probiotics Antimicrob Proteins; 2020 Sep 15; 12(3):1002-1011. PubMed ID: 31760594
    [Abstract] [Full Text] [Related]

  • 5. The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats.
    Cavalcante RGS, de Albuquerque TMR, de Luna Freire MO, Ferreira GAH, Carneiro Dos Santos LA, Magnani M, Cruz JC, Braga VA, de Souza EL, de Brito Alves JL.
    Nutr Metab Cardiovasc Dis; 2019 Dec 15; 29(12):1408-1417. PubMed ID: 31640890
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral administration of Lactobacillus fermentum post-weaning improves the lipid profile and autonomic dysfunction in rat offspring exposed to maternal dyslipidemia.
    de Oliveira Y, Cavalcante RGS, Cavalcanti Neto MP, Magnani M, Braga VA, de Souza EL, de Brito Alves JL.
    Food Funct; 2020 Jun 24; 11(6):5581-5594. PubMed ID: 32524104
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lactobacillus fermentum NCIMB 5221 and NCIMB 2797 as cholesterol-lowering probiotic biotherapeutics: in vitro analysis.
    Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Rodes L, Prakash S.
    Benef Microbes; 2015 Jun 24; 6(6):861-9. PubMed ID: 26322545
    [Abstract] [Full Text] [Related]

  • 11. Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats.
    Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Labbé A, Rodes L, Kahouli I, Prakash S.
    Appl Microbiol Biotechnol; 2014 Jan 24; 98(1):115-26. PubMed ID: 24121931
    [Abstract] [Full Text] [Related]

  • 12. Probiotic Characterization of Cholesterol-Lowering Lactobacillus fermentum MJM60397.
    Palaniyandi SA, Damodharan K, Suh JW, Yang SH.
    Probiotics Antimicrob Proteins; 2020 Sep 24; 12(3):1161-1172. PubMed ID: 31432401
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potentially Probiotic Limosilactobacillus fermentum Fruit-Derived Strains Alleviate Cardiometabolic Disorders and Gut Microbiota Impairment in Male Rats Fed a High-Fat Diet.
    de Araújo Henriques Ferreira G, Magnani M, Cabral L, Brandão LR, Noronha MF, de Campos Cruz J, de Souza EL, de Brito Alves JL.
    Probiotics Antimicrob Proteins; 2022 Apr 24; 14(2):349-359. PubMed ID: 35066820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.
    Cruz Neto JPR, de Oliveira AM, de Oliveira KÁR, Sampaio KB, da Veiga Dutra ML, de Luna Freire MO, de Souza EL, de Brito Alves JL.
    Probiotics Antimicrob Proteins; 2024 Jun 24; 16(3):752-762. PubMed ID: 37119497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota.
    Lye HS, Kato T, Low WY, Taylor TD, Prakash T, Lew LC, Ohno H, Liong MT.
    J Biotechnol; 2017 Nov 20; 262():75-83. PubMed ID: 28935567
    [Abstract] [Full Text] [Related]

  • 20. Consumption of Probiotic Lactobacillus fermentum MTCC: 5898-Fermented Milk Attenuates Dyslipidemia, Oxidative Stress, and Inflammation in Male Rats Fed on Cholesterol-Enriched Diet.
    Yadav R, Khan SH, Mada SB, Meena S, Kapila R, Kapila S.
    Probiotics Antimicrob Proteins; 2019 Jun 20; 11(2):509-518. PubMed ID: 29754388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.